Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Corcept Therapeutics (CORT) Tax Rate (2017 - 2026)

Corcept Therapeutics (CORT) has disclosed Tax Rate for 10 consecutive years, with 29.07% as the latest value for Q1 2026.

  • For Q1 2026, Tax Rate rose 14240.0% year-over-year to 29.07%; the TTM value through Mar 2026 reached 290.48%, down 29201.0%, while the annual FY2025 figure was 49.94%, 6250.0% down from the prior year.
  • Tax Rate hit 29.07% in Q1 2026 for Corcept Therapeutics, up from 145.09% in the prior quarter.
  • Across five years, Tax Rate topped out at 31.61% in Q4 2022 and bottomed at 145.09% in Q4 2025.
  • Average Tax Rate over 5 years is 6.13%, with a median of 13.86% recorded in 2023.
  • Year-over-year, Tax Rate crashed -14879bps in 2025 and then skyrocketed 14240bps in 2026.
  • Corcept Therapeutics' Tax Rate stood at 31.61% in 2022, then plummeted by -53bps to 14.82% in 2023, then tumbled by -75bps to 3.7% in 2024, then tumbled by -4016bps to 145.09% in 2025, then surged by 120bps to 29.07% in 2026.
  • According to Business Quant data, Tax Rate over the past three periods came in at 29.07%, 145.09%, and 28.87% for Q1 2026, Q4 2025, and Q3 2025 respectively.